Press Room
![](https://www.kidney.org/sites/default/files/styles/nephron_custom_scale_crop_400_400/public/styles/large/public/Invokana%20PR%20600x400%20%28002%29.jpg)
September 2019
FDA Approves New Drug to Treat Diabetes-Related Kidney Disease
The National Kidney Foundation Statement about INVOKANA® (Canagliflozin)
New York, NY–Sept. 30, 2019— “The Janssen Pharmaceutical Companies of Johnson & Johnson...
![](https://www.kidney.org/sites/default/files/styles/nephron_custom_scale_crop_400_400/public/styles/large/public/Lancet%20SCM%20600x400.jpg)
September 2019
The Lancet Publishes Study Showing Hyperkalemia Drug May Help Kidney Patients Stay on Hypertension Treatment
Results presented at late-breaking trial session of National Kidney Foundation's 2019 Spring Clinical Meetings
New York, NY–Sept. 15, 2019— The respected peer-reviewed, medical...